Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01391364 · ClinicalTrials.gov registry record · NA
A Study to Evaluate a Modified Contact Lens
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 438
- Enrollment target
NCT01391364 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 438 participants.
The verdict
NCT01391364, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 438 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate the product performance of SofLens daily disposable contact lenses packaged in an investigational Test solution versus SofLens daily disposable contact lenses packaged in the currently marketed solution (Control), as it relates to comfort when worn by adapted soft contact lens wearers on a daily-wear basis.
Interventions
- DEVICE SofLens in investigational solution
- DEVICE SofLens in currently marketed solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 438 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01391364
The ClinicalTrials.gov registry entry for NCT01391364 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 438 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SofLens in investigational solution is the first listed.
NCT01391364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01391364 about?
NCT01391364 is a clinical study titled "A Study to Evaluate a Modified Contact Lens". This study is being conducted to evaluate the product performance of SofLens daily disposable contact lenses packaged in an investigational Test solution versus SofLens daily disposable contact lenses packaged in the currently marketed solution (Control), as it relates to comfort when worn by adapte...
What is the current status of trial NCT01391364?
This trial is currently completed. It is a NA study. The enrollment target is 438 participants. The study started on 2011-04. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01391364?
The interventions under investigation include: SofLens in investigational solution (DEVICE), SofLens in currently marketed solution (DEVICE).
Who is sponsoring clinical trial NCT01391364?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.